Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study.
- DOI
- 10.1186/s12920-024-02033-z
- Published
- 2024-11-21
- Container
- BMC Med Genomics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12920-024-02033-z,
title = {Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study.},
author = {Hansen KH and Lyng MB and Kodahl AR and Asmussen JT and Arshad A and Petersen H and Krogh L and Ehmsen S and Kristensen TK and Ditzel HJ.},
year = {2024},
journal = {BMC Med Genomics},
doi = {10.1186/s12920-024-02033-z},
url = {https://doi.org/10.1186/s12920-024-02033-z}
}RIS
TY - JOUR TI - Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study. AU - Hansen KH AU - Lyng MB AU - Kodahl AR AU - Asmussen JT AU - Arshad A AU - Petersen H AU - Krogh L AU - Ehmsen S AU - Kristensen TK AU - Ditzel HJ. PY - 2024 JO - BMC Med Genomics DO - 10.1186/s12920-024-02033-z UR - https://doi.org/10.1186/s12920-024-02033-z ER -
APA
KH, H., MB, L., AR, K., JT, A., A, A., H, P., L, K., S, E., TK, K., & HJ., D. (2024). Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study.. BMC Med Genomics. https://doi.org/10.1186/s12920-024-02033-z
Source records
- europe-pmc · retrieved 2026-11-10T20:44:21.285Z
- doaj · retrieved 2026-11-10T20:44:21.401Z